EVELYN BOATENG: Open Payments
NPI 1588154363 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 18 payments from 4 companies in 2025. Trend: 2023 $1,075 · 2024 $532 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $376 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| ABBVIE INC. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
Products named: CAPLYTA, FANAPT, VRAYLAR, SPRAVATO.
Industry payments across CT — which companies pay providers there.
